Sep.05
12:58 PM ET
Friday, 5 Sep 2008
Earlier this week I blogged about Eli Lilly's "Coming Soon" banner ad I spotted in the online edition of "The New England Journal of Medicine." It's designed to generate buzz about the company's crucial new bloodthinner that could win Food and Drug Administration approval this month. Read More
Topics:Stock Market | Medicine | Pharmaceuticals
Companies:Eli Lilly and Company | Amylin Pharmaceuticals | S | Sciele Pharma Inc | Bristol-Myers Squibb Co | Dendreon Corp
Sep.02
6:36 PM ET
Tuesday, 2 Sep 2008
Following are the day’s biggest winners and losers. Find out why shares of American Airlines and Prudential popped while Gilead Sciences and Chesapeake Energy dropped. Read More
VIDEO | COMPANIES : Sciele Pharma Inc
Discussing December chain store sales results, with Eric Beder, Brean Murray & Co., Inc. and Patti Freeman Evans, Forres...
The latest survey findings on Manhattan real estate, with Jonathan Miller, Miller Samuel, Inc. president/CEO
Endo Pharma is buying Indevus Pharma for $4.50 a share, reports CNBC's Mike Huckman
The outlook for an economic recovery, with Anirvan Banerji, of the Cycle Research Institute, and Maria Fiorini Ramirez, ...
The healthcare bubble may be the next to collapse, says Dr. Winifred Hayes, Hayes Inc. Founder and CEO
More Videos
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC MOBILE | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2009 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes